chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient vaccinated 7/12/2021,  admitted 7/31/2021 tested positive for COVID 7/31/2021 Discharged home 8/9/2021  Hospitalization Admit Date/Time: 7/31/2021  6:06 PM Discharge Date: 08/09/21  PCP name and Address:  No primary care provider on file. No primary physician on file. Referring provider name and address:  No referring provider defined for this encounter.   Chief Concern, Brief History of Present Illness, and Hospital Course organized by problem:  Patient is a 58 y/o male with a PMH of hyperlipidemia who presented to ED on 7/31 for dyspnea.  On arrival, the patient had O2 sats: 84% on room air.  The patient endorsed a dry cough and diarrhea for approximately 1 week. He also started having a fever 3-4 days prior to admission with a Tmax: 101F, decreased appetite, generalized weakness, and decreased sleep.  The patient went to an outpatient clinic and tested negative for COVID and flu at that time.  He reports receiving the Johnson and Johnson COVID vaccine 3 weeks ago.  The patient was tested for COVID-19 at Hospital and tested positive. It is important to note the patient was diagnosed with pneumonia around 1 month ago due to worsening cough; however, no chest x-ray was obtained at that time.    Acute hypoxic respiratory failure 2/2 COVID-19 pneumonia - Presented with one week of symptoms, tested positive in ED on 7/31 - Received Johnson and Johnson vaccine 7/12/2021 - He required HFNC for appropriate oxygenation and was originally admitted to hospital medicine, but on 8/2/21 had to be transferred to MICU due to increasing O2 requirement - He finished 5 day course of remdesivir on 8/4/21 - He received dose of tocilizumab 800mg on 8/2/21 due to worsening hypoxia - He finished 10 day course of dexamethasone on 8/9/21 - Inflammatory markers including ferritin, CRP, d-dimer appropriately decreased towards normal - Pt was weaned to nasal cannula and transferred out of the ICU on 8/4/21. He was further weaned to 2L via NC with goal to maintain SpO2 > 92%  - Walk test prior to discharged showed very minimal decrease in SpO2 with fast recovery when at rest - He will be discharged on home oxygen.    Mild Transaminitis  - Possibly related to COVID-19 infection, and possibly relation to tocilizumab and remdesivir - ALT now normalized and AST improved and close to normal   Hyperglycemia  - Steroid induced - HgbA1c 5.8% in June 2021  - Glucose appropriate prior to discharge
Headache, neck and shoulder soreness started that evening. Woke up the next morning with general feeling of crumminess and extreme exhaustion. Developed a fever, varying from 99.9 - 102.0, that lasted from mid-day Saturday (the next day) until Sunday evening (more than 48 hours after shot), with accompanying chills, tiredness. General "post flu" weakness and fatigue on Sunday. Treated with Tylenol as necessary, heat for muscle aches, slept more than usual.
"Deep rash" different from the maculopapular rash that had been persistent since the time of vaccination.  Persistent cough, rhinorrhea, nasal congestion. Normal vitals and otherwise normal exam. Diagnosed with nonthrombocytopenic purpura following normal CBC, electrolytes/renal function, urinalysis, and PT/PTT.  Discharged from the ED with outpatient follow-up.
Narrative: Patient received 1st dose of Moderna covid-19 vaccine. Shortly after, patient developed lightheadedness that resolved with observation. No treatment or additional monitoring required.
Light headed, fever, shaking on the inside, cold chills, no apatite, ears feel like on fire, increase in anxiety, fear.
Right leg with erythema and edema. Mom brought baby in. Advised to ice x20' q hr. Motrin 5mg prn.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Pertinent medical history, drug reactions or allergies were unspecified. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (dose, dose number, route, anatomical location were unspecified). Concomitant therapies were unspecified. On an unknown date the patient experienced bruising and hardness at the injection site. Treatment given for the adverse event was unspecified. The outcome of bruising and hardness at the injection site was reported as recovered on an unspecified date. The relatedness between the events and PNEUMOVAX 23 was not reported. Additional information has been requested.
Initial symptoms became noticeable about 2 weeks (around the second week of APR 21) after second dose of vaccine. Symptoms began as a drop in strength and endurance. These continued until about mid AUG 21 when my strength and endurance got so bad that I could not run and my strength significantly. Fatigue was a major issue and also inflammation in all my joints and lower back. A small tendon tear also occurred in my left arm during this time period as well which required physical therapy. The inflammation in my knees also resulted in my requiring physical therapy for my knees as well which also became so bad that I had to submit and was approved for a running profile. The inflammation was so bad and consistent that I was using a prescribed anti-inflammatory (Diclofenac Sodium) which resulted in kidney issues. I am no longer able to use NSAIDs and the joint pain is constant and limits my normal activities to the point that I am barely able to do some of the activities that I usually do or that are required for my job. Strength and Endurance have not returned to normal levels at this time and due to limitations caused by the increased inflammation in my joints, it is unlikely that they will do so.
Hospitalization for altered mental status/encephalopathy  and COVID-19 pneumonia on dates 5/7/2022- 5/16/2022. Treated with ascorbic acid, cholecalciferol, dexamethasone, Remdesivir,  and zinc.
SECOND DOSE OF JYNNEOS WAS ADMINISTERED ON DAY 18 ON DAY 28 (INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
There is a possibility Pt may have received 0.25 ml of vaccine rather than the recommended 0.2 ml. of the Moderna Bivalent presentation for 6 months to 5 years.  A staff member was not aware of the correct dosing of the bivalent vaccine. The system in place for drawing up vaccine and administering vaccine may have allowed for staff member to have drawn up 0.25 ml and another staff member to give the vaccine. It cannot be determined if the correct or incorrect amount was drawn up or given. There has been no reported adverse reaction from the parents to date.
Swollen lips and swollen tongue.  Hospital adminstered meds like benadryl
Information has been received from a registered nurse, concerning her male friend patient, with no known medical history or allergies, who in "approximately 2006", was vaccinated subcutaneously with a dose of PNEUMOVAX 23 (dose and lot number not reported). No other vaccines were administered that day. The nurse did not know about concomitant therapy. The nurse reported that about a week later "in approximately 2006", the patient reported her that after vaccination, he had injection site swelling, injection site redness and heat at injection site; his arm was sore and he had body aches. The nurse reported that she thought the reaction had resolved in about 10 days. The nurse stated that the patient's friend received the same injection right after the patient did, and he did not have any problems. The nurse also stated that the patient had very little subcutaneous fat. The nurse also specified that she would not give PNEUMOVAX 23 subcutaneously; she only give it intramuscularly at the time of reporting. The patient outcome was unknown at the time of reporting. This is one of several reports from the same source. Additional information is not expected.
Patient has a rasied, irritated blister on left leg that presented approximately 48 hrs after injection.
Patient c/o mouth & tongue tingling, lightheadedness.  Patient reported taking 1pm insulin and not eating.  Given 2 pieces of candy, coke.  EMS called at 1706.  EMS arrived, assessed pt and checked FSBS which was 124 after 2 pieces of candy and a coke.  Patient declined transport to hospital for further evaluation.
I lost muscle control while playing tennis for about 5 minutes.  After that I felt very tired, queezy, dizzy for about two days.
Narrative:  Patient received dose 1 of Moderna COVID-19 vaccine on 3/11/21 from clinic. Vaccine was administered to patient without complications and patient was observed for 15 minutes post-vaccination without any adverse effects. No documentation as to any adverse effects following the 15 minutes post-vaccination. 11 days later on 3/22/21, EMS was dispatched to patient's home and patient was found lying supine, unconscious, and unresponsive to stimuli. Patient was noted to have shallow breathing per EMS staff, and was subsequently brought to the hospital. Per family, patient lives alone and was feeling well - they had spoken to her two days prior to the event. Per family patient did not have recent fevers, vomiting, diarrhea, or cough. Also no recent medication changes or trauma. PMH includes stroke approx. 8 years ago, gout, HLD, HTN, and RLS. BP upon admission was 126/93, HR 123, temp 37.1 degrees Celcius, RR 28. Patient noted to smell of urine. CT showed large completed right sided infarct consistent with MCA stroke. Per neurology the lesion was not recoverable and patient would be unlikely to regain any function. Family was notified and poor prognosis was discussed. Patient has been very clear in the past that she would prefer "to go when her time came". She had a DNR And DNI as well. Daughter requested to pursue comfort measures for patient, therefore she was transferred to hospice care. Patient passed away the following day on 3/23/21. Death very unlikely due to COVID-19 vaccination since CT imaging clearly showed cerebral infarct and patient had a PMH of stroke.
This spontaneous report was received from a office manager whom reported the shipment of PROQUAD, and sterile diluent (manufacturer unknown) which similar, and it could lead to confusion. It was also reported that the products were not administered, and no adverse effects were reported since there was not patient involved. Additional information has been requested.
Had shot in the evening. went to bed. woke up and my left upper thigh was numb from the middle of the kneecap around the outside of my leg to the middle of the back all the way up to my hip. I emailed my primary who replied on monday and said to call nurse line. the nurse line then sent me to covid line which then got me to a nurse who was speaking to covid dr. She realyed information that he was telling her. He said yes this has been reported and yes this is not common but is known. They do not know why, or how long this will last other than usually a while. when asked how long was a while they did not know. They said there was nothing that they could do to help and if it moves anymore as at this point it was moving past my knee to the outside of my calf also to go be seen.  They do not feel a reason to come in as there is nothing that can be done. As of today I still have no feeling in my left upper leg in the same location with slight to minimal improvement on my back side but it has also moved to my outside calf area slightly. I am 6 days past vaccinations with 12 hours after vaccine reaction but who knows because I was sleeping. It is constant numbness and not intermittent. I am able to walk still, it is just really annoying. I do plan to go to my primary but I do not know what this will solve as they said I do not need to be seen as nothing can be done.  I asked if it can travel to my whole leg and they stated that yes it can travel they do not know in my case specifically if it will.  I clicked office visit below because I had to speak to nurse/dr. over the phone. Right now I am just trying to ignore it and live my life.
Patient stated he developed hypertension following Pfizer vaccination. He never had elevated blood pressure in the past.
felt not so great; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st August 2021, the patient received the 1st dose of Shingrix. On 31st August 2021, less than a day after receiving Shingrix, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was recovered/resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingrix.  Additional details were reported as follows: The case was reported by patient's wife. Age at vaccination was not reported. The patient got dose 1 of Shingrix on the day of reporting. The patient felt not so great for 3 hours and at the time of reporting, felt great. The patient was expecting the worse but it was not bad. No contact details were available. The case had been linked with US2021AMR187034 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR187034:same reporter
1. General malaise followed by numbness around nose and lips.   Took Benadryl 1.5 hours after vaccine do to worsening of numbness.    2. The following day flare in joint areas of arthritis.   3. Out break of herpes 2 which had been dormant for three years.  Out break has continued since vaccine.  4.  Numbness around mouth has persisted since vaccine.  5.  Change in ability to process information.
the medication was given to the wrong person, the client was due for a booster and the last two doses were Pfizer. we did observed the client for 20 minutes and there were no adverse reactions seen. we did go back to the care home 45 later with the supervisor.  the client showed no adverse reactions.
no adverse event; a 35-year-old patient was administered a dose of PROQUAD; due for next VARIVAX, but was also due for an M-M-R II dose. Because of this, it was decided to give PROQUAD; due for next VARIVAX, but was also due for an M-M-R II dose. Because of this, it was decided to give PROQUAD; This spontaneous report has been received from a medical assistant referring to a 35 year old female patient. Information about pertinent medical history and drug reactions/allergies was not provided. Concomitant therapies included sterile diluent.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) for prophylaxis (dose detail, anatomical location, route of administration, batch/lot # and expiration date were not reported). On 24-MAY-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis (lot# R013568, expiration date 13-MAY-2020; dose detail, anatomical location and route of administration were not reported). On 24-JUN-2019, the patient was accidentally vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA (recombinant Human albumin)) (PROQUAD) for prophylaxis (lot # R026362, expiration date 15-MAR-2020; dose detail, anatomical location and route of administration were not reported).  On 24-JUN-2019, the patient was due for next varicella virus vaccine live (oka/merck)(VARIVAX), but was also due for an measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) dose. Because of this, it was decided to give measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA (recombinant Human albumin))(PROQUAD) (product administered to patient of inappropriate age, wrong product administered and interchange of vaccine products). It was only after the fact that they noticed that this was not indicated for patients that was 35 years of age. The patient had complained of no adverse events thus far.
SORE ARM MILD FOR 6 DAYS, VERY TIRED UNABLE TO WORK, MUSCLE PAIN IN LOW BACK AND SHOULDERS, SEVERE HEADACHE, FEVER 99.9 CHILLS, SHIVERS, LASTING FROM 12/28/21 TO 12/30/21. ON OR ABOUT 1/4/2022 I NOTICED A SMALL RED SPOT THAT BURNED AND ITCHED ON MY RIGHT ABDOMINAL AREA AT THE WAISTLINE JUST FORWARD OF THE HIP BONE.  BY THURSDAY 1/6/2022 THE SPOT HAD BECOME MORE PAINFUL AND DEVELOPED A WHITE PUFFY HEAD (PHOTO AVAILABLE). BY 1/8/2022 THE SPOT HAD A CLEAR FLUID SACK ON TOP (PHOTO AVAILABLE) THE BURNING AND ITCHING INTENSIFIED AS THE SPOT DEVELOPED. ON 1/9/2022 THE CLEAR FLUID WAS GONE AND THE SPOT SEEMED TO BE DRYING ON 1/10/2022 THE SPOT WAS NO LONGER BURNING AND THE ITCHING WAS SUBSIDING (PHOTO AVAILABLE.)
Patient returned to pharmacy on 11/20/17 S/P PREVNAR 13 immunization c/o swelling at sight of injection and fever. Pharmacist described the upper aspect of left arms as silver dollar sized dark area and generalized redness about 4 inches in length. Patient was advised to ice arm and to seek attention at urgent care. Follow up T/C with patient on 11/24/17; Mostly resolved - pt did not seek medical attn. Again advised to MD if condition returned.
The patient's mother states 3 days after receiving the 1st set of baby shots, the patient was diagnosed with "infantile spasms" and was seen by a Pediatric Neurologist. At birth the patient was diagnosed with decreased muscle tone and was receiving therapy. The patient's mother states that before the shots the patient was moving her arms, smiling and "talking", but now, the patient just looks at her and does not move hre arms or legs.
Dizziness, itching, sore arm, vitals WNL. Apple juice, water, crackers.
Hypomanic for 2 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: er8737) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19: Yes; "Rheumatoid arthritis" (unspecified if ongoing); "drug allergy with beta blocker medication" (unspecified if ongoing). There were no concomitant medications. The following information was reported: HYPOMANIA (non-serious), outcome "recovered", described as "Hypomanic for 2 hours".  Additional Information: It was reported that prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. the patient experienced hypomanic for 2 hours. The patient had uncontrolled rheumatoid arthritis and thought it was cured. All rheumatoid arthritis symptoms gone but patient was told Hypomanic.  No follow-up attempts are possible. No further information is expected.
1/11/21 at 0625 recieved vaccine.  Had taken benadryl to help sleep due to working night shift.  Woke up at 2:30pm and noticed swelling to face and inside of inner cheeks.  Went to Free Standing ER and recieved Hydroxyzine to help reduce swelling and sent home.  1/12/21 this am noticed the swelling in cheeks was better but now has swollen necks glands and facial swelling is slightly better in cheek better, but lips and rest of face of face still swollen.
Received flu vaccine at approximately 10:30am 10/11/07 at 2:00 pm felt slight "lump" in throat which persisted took Benadryl 25mg PO at 2:30 pm.
Client for additional dose. 1st dose Janssen. Client requested Moderna additional dose. Client rec'd Moderna, 0.5ml Moderna. Client should have received 0.25ml Moderna dose. Client informed of wrong dose via telephone on 10/25/2021. Client informed that there is no evididence of harm from receiving this dose.
The patient experienced a vasovagal syncope episode mere minutes after receiving the shot. The patient fell to the ground, striking her face and head on concrete, and severely breaking her jaw and teeth.
fever given APAP;nauseous, stomach pain;11OCT check w/MD a/receiving 2nd dose FEB26th;
Initial misuse report received from a healthcare professional on 23 May 2013. It was reported that an expired dose of MENACTRA was administered to an 18-year-old patient. No adverse event was reported. Documents held by sender: none.
On November 13 I got vaccinated at 2 pm. On November 14, my period started normally. On November 15, I was bleeding abundantly and had a lot of blood clots. Something that has never happened to me before. I think it's a side effect of the vaccine because it's really weird.
This spontaneous case, initially received from a pharmacist on 24-Sep-2018, concerning a 41-year-old, elderly patient of an unspecified gender. The patient's medical history and concomitant medications were not available. Since 03-Sep-2018, the refrigerator's temperature fluctuated above 47F and FLUCELVAX QIVc vaccine exposed to temperatures in the range of 47F to 50.9F. On 12-Sep-2018, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location, batch number and expiry date: not reported) which underwent temperature excursion. The patient did not experience any adverse drug reaction after the vaccination. The reporter assessed this case as non-serious. This case 201804094 cross-linked to original case 201804076 due to the same reporter. Non-significant follow-up received from the reporter on 14-Nov-2018: Med info number (SEQ18-04086) was updated in the additional information tab. No changes were made in the narrative.
Sedation, Myalgia & Fever  Narrative:  Initial vaccine dose administered 1/5/21. On 1/6/21 reported fever, body aches and severe fatigue.
Child became nauseated and pale after receiving immunizations. She also displayed bluish coloration around the mouth. After cool compresses and legs were elevated child was WNL status. Mother took child to PCP for evaluation which was WNL.
Pfizer bivalent 5y-11 vial not diluted & given to two patients.  RN discovered it & questioned LPN that prepared the vial, The Nurse manager is aware & practice manager as well. Father received a call also
This spontaneous report was received from a medical assistant refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with an improperly stored ROTATEQ orally (dose and lot # were not reported). Patients were also vaccinated with improperly stored TD. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccine name is in my records from the clinic, I don't the name with me, sorry. After I received the vaccine I went home and noticed my let arm was sore and heavy. The next day early in the morning I felt a strong pain on my right leg in the area below my butt sheek next to my hip. It was hard to get up to walk. So, I rested and used some Ice/Heat on the area. Today is Thursday I am still in pain, will be going to the ER tomorrow.